Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11498 | 977 | 38.0 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
11498 | 1 | GLYCATED LDL//NEPHROL ENDOCRINOL P//TRIGLYCERIDE SECRETION RATE | 977 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GLYCATED LDL | authKW | 225010 | 1% | 60% | 12 |
2 | NEPHROL ENDOCRINOL P | address | 70317 | 0% | 75% | 3 |
3 | TRIGLYCERIDE SECRETION RATE | authKW | 70317 | 0% | 75% | 3 |
4 | TRANSVASCULAR LIPOPROTEIN TRANSPORT | authKW | 62505 | 0% | 100% | 2 |
5 | LIPOPROTEIN COMPOSITION | authKW | 52724 | 1% | 19% | 9 |
6 | GLYCATED LOW DENSITY LIPOPROTEIN | authKW | 46876 | 0% | 50% | 3 |
7 | GLYCATED APOLIPOPROTEIN B | authKW | 41669 | 0% | 67% | 2 |
8 | TRITON WR1339 | authKW | 35156 | 0% | 38% | 3 |
9 | ABT GERIATR STOFFWECHSELERKRANKUNGEN 2 | address | 31253 | 0% | 100% | 1 |
10 | AND E | authKW | 31253 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 12474 | 44% | 0% | 425 |
2 | Medicine, General & Internal | 1225 | 18% | 0% | 171 |
3 | Peripheral Vascular Diseases | 774 | 9% | 0% | 87 |
4 | Cardiac & Cardiovascular System | 652 | 11% | 0% | 110 |
5 | Medical Laboratory Technology | 397 | 4% | 0% | 35 |
6 | Nutrition & Dietetics | 170 | 4% | 0% | 40 |
7 | Medicine, Research & Experimental | 147 | 6% | 0% | 56 |
8 | Physiology | 18 | 3% | 0% | 25 |
9 | Biochemistry & Molecular Biology | 14 | 8% | 0% | 81 |
10 | Biophysics | 10 | 2% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEPHROL ENDOCRINOL P | 70317 | 0% | 75% | 3 |
2 | ABT GERIATR STOFFWECHSELERKRANKUNGEN 2 | 31253 | 0% | 100% | 1 |
3 | BIOSCI INGN | 31253 | 0% | 100% | 1 |
4 | DIABET METAB ENDOCRINOL MED | 31253 | 0% | 100% | 1 |
5 | ENDOCRINOL NUTRUNIT LIPIDS METAB | 31253 | 0% | 100% | 1 |
6 | HLTH SCI SW MED CLIN NUTR | 31253 | 0% | 100% | 1 |
7 | HLTH SCI SW MED HUMAN NUTR | 31253 | 0% | 100% | 1 |
8 | INSERM U32 | 31253 | 0% | 100% | 1 |
9 | INTERNAL MED PHYSIOL PATHOPHYSIOL | 31253 | 0% | 100% | 1 |
10 | ION SOURCE BIOTECHNOL | 31253 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA DIABETOLOGICA LATINA | 13958 | 1% | 3% | 14 |
2 | DIABETES & METABOLISM | 11936 | 3% | 1% | 33 |
3 | DIABETES | 9962 | 6% | 1% | 62 |
4 | ARTERIOSCLEROSIS | 9778 | 2% | 2% | 15 |
5 | METABOLISM-CLINICAL AND EXPERIMENTAL | 9139 | 5% | 1% | 51 |
6 | DIABETES-METABOLISM REVIEWS | 8175 | 1% | 3% | 9 |
7 | DIABETOLOGIA | 6287 | 4% | 0% | 41 |
8 | DIABETES CARE | 6005 | 5% | 0% | 47 |
9 | DIABETES NUTRITION & METABOLISM | 5924 | 1% | 2% | 11 |
10 | ATHEROSCLEROSIS | 4901 | 4% | 0% | 41 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DUNN, FL , (1992) MANAGEMENT OF HYPERLIPIDEMIA IN DIABETES-MELLITUS.ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. VOL. 21. ISSUE 2. P. 395 -414 | 94 | 73% | 10 |
2 | HOWARD, BV , (1987) LIPOPROTEIN METABOLISM IN DIABETES-MELLITUS.JOURNAL OF LIPID RESEARCH. VOL. 28. ISSUE 6. P. 613-628 | 59 | 73% | 568 |
3 | PURNELL, JQ , BRUNZELL, JD , (1997) EFFECT OF INTENSIVE DIABETES THERAPY ON DIABETIC DYSLIPIDEMIA.DIABETES REVIEWS. VOL. 5. ISSUE 4. P. 434 -444 | 63 | 71% | 3 |
4 | GINSBERG, HN , (1991) LIPOPROTEIN PHYSIOLOGY IN NONDIABETIC AND DIABETIC STATES - RELATIONSHIP TO ATHEROGENESIS.DIABETES CARE. VOL. 14. ISSUE 9. P. 839-855 | 73 | 59% | 201 |
5 | TASKINEN, MR , (1990) HYPERLIPEMIA IN DIABETES.BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM. VOL. 4. ISSUE 4. P. 743-775 | 71 | 69% | 115 |
6 | DUNN, FL , (1992) PLASMA-LIPID AND LIPOPROTEIN DISORDERS IN IDDM.DIABETES. VOL. 41. ISSUE . P. 102-106 | 39 | 91% | 28 |
7 | ABBATE, SL , BRUNZELL, JD , (1990) PATHOPHYSIOLOGY OF HYPERLIPIDEMIA IN DIABETES-MELLITUS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 16. ISSUE . P. S1-S7 | 48 | 73% | 32 |
8 | VERGES, BL , (1999) DYSLIPIDAEMIA IN DIABETES MELLITUS - REVIEW OF THE MAIN LIPOPROTEIN ABNORMALITIES AND THEIR CONSEQUENCES ON THE DEVELOPMENT OF ATHEROGENESIS.DIABETES & METABOLISM. VOL. 25. ISSUE . P. 32 -40 | 39 | 56% | 66 |
9 | BROWN, WV , (1994) LIPOPROTEIN DISORDERS IN DIABETES-MELLITUS.MEDICAL CLINICS OF NORTH AMERICA. VOL. 78. ISSUE 1. P. 143-161 | 46 | 51% | 70 |
10 | GARG, A , (1994) MANAGEMENT OF DYSLIPIDEMIA IN IDDM PATIENTS.DIABETES CARE. VOL. 17. ISSUE 3. P. 224 -234 | 41 | 57% | 23 |
Classes with closest relation at Level 1 |